A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening

被引:32
作者
Gilbert, Daniel F. [1 ,2 ]
Erdmann, Gerrit [1 ,2 ]
Zhang, Xian [1 ,2 ]
Fritzsche, Anja [1 ,2 ]
Demir, Kubilay [1 ,2 ]
Jaedicke, Andreas [1 ,2 ]
Muehlenberg, Katja [3 ]
Wanker, Erich E. [3 ]
Boutros, Michael [1 ,2 ]
机构
[1] German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany
[2] Heidelberg Univ, Dept Cell & Mol Biol, Heidelberg, Germany
[3] Max Delbrueck Ctr Mol Med MDC, Berlin, Germany
关键词
HUNTINGTONS-DISEASE MUTATION; SYNTHETIC LETHALITY; MUTANT HUNTINGTIN; CANCER; DYSFUNCTION; INHIBITORS; TOXICITY; NUCLEUS; PATHWAY;
D O I
10.1371/journal.pone.0028338
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cell-based high-throughput RNAi screening has become a powerful research tool in addressing a variety of biological questions. In RNAi screening, one of the most commonly applied assay system is measuring the fitness of cells that is usually quantified using fluorescence, luminescence and absorption-based readouts. These methods, typically implemented and scaled to large-scale screening format, however often only yield limited information on the cell fitness phenotype due to evaluation of a single and indirect physiological indicator. To address this problem, we have established a cell fitness multiplexing assay which combines a biochemical approach and two fluorescence-based assaying methods. We applied this assay in a large-scale RNAi screening experiment with siRNA pools targeting the human kinome in different modified HEK293 cell lines. Subsequent analysis of ranked fitness phenotypes assessed by the different assaying methods revealed average phenotype intersections of 50.7 +/- 2.3%-58.7 +/- 14.4% when two indicators were combined and 40-48% when a third indicator was taken into account. From these observations we conclude that combination of multiple fitness measures may decrease false-positive rates and increases confidence for hit selection. Our robust experimental and analytical method improves the classical approach in terms of time, data comprehensiveness and cost.
引用
收藏
页数:10
相关论文
共 36 条
[1]   What determines the intracellular ATP concentration [J].
Ataullakhanov, FI ;
Vitvitsky, VM .
BIOSCIENCE REPORTS, 2002, 22 (5-6) :501-511
[2]   Systemic energy homeostasis in Huntington's disease patients [J].
Aziz, N. Ahmad ;
Pijl, Hanno ;
Frolich, Marijke ;
Snel, Marieke ;
Streefland, Trea C. M. ;
Roelfsema, Ferdinand ;
Roos, Raymund A. C. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (11) :1233-1237
[3]   EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity [J].
Bieschke, Jan ;
Russ, Jenny ;
Friedrich, Ralf P. ;
Ehrnhoefer, Dagmar E. ;
Wobst, Heike ;
Neugebauer, Katja ;
Wanker, Erich E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (17) :7710-7715
[4]   A NONISOTOPIC, HIGHLY SENSITIVE, FLUOROMETRIC, CELL-CELL ADHESION MICROPLATE ASSAY USING CALCEIN AM-LABELED LYMPHOCYTES [J].
BRAUTBOUCHER, F ;
PICHON, J ;
RAT, P ;
ADOLPHE, M ;
AUBERY, M ;
FONT, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 178 (01) :41-51
[5]   Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation [J].
Carmichael, J ;
Sugars, KL ;
Bao, YP ;
Rubinsztein, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) :33791-33798
[6]   Huntingtin coordinates the dynein-mediated dynamic positioning of endosomes and lysosomes [J].
Caviston, Juliane P. ;
Zajac, Allison L. ;
Tokito, Mariko ;
Holzbaur, Erika L. F. .
MOLECULAR BIOLOGY OF THE CELL, 2011, 22 (04) :478-492
[7]   Harnessing synthetic lethal interactions in anticancer drug discovery [J].
Chan, Denise A. ;
Giaccia, Amato J. .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) :351-364
[8]   DNA MINOR GROOVE-BINDING LIGANDS - A DIFFERENT CLASS OF MAMMALIAN DNA TOPOISOMERASE-I INHIBITORS [J].
CHEN, AY ;
YU, C ;
GATTO, B ;
LIU, LF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :8131-8135
[9]   The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease [J].
Chiang, Ming-Chang ;
Chern, Yijuang ;
Juo, Chiun-Gung .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (09) :1111-1120
[10]   PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer [J].
Crowder, Robert J. ;
Phommaly, Chanpheng ;
Tao, Yu ;
Hoog, Jeremy ;
Luo, Jingqin ;
Perou, Charles M. ;
Parker, Joel S. ;
Miller, Melinda A. ;
Huntsman, David G. ;
Lin, Li ;
Snider, Jacqueline ;
Davies, Sherri R. ;
Olson, John A., Jr. ;
Watson, Mark A. ;
Saporita, Anthony ;
Weber, Jason D. ;
Ellis, Matthew J. .
CANCER RESEARCH, 2009, 69 (09) :3955-3962